Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer

Oral Diseases

Volumn 16, Issue 7, 2010, Pages 668-673

  Sharma, R ^a   Panda, N K ^a   Khullar, M ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

CYP1A1; CYP2A13; GSTM1; head and neck cancer; methylation; smoking

Indexed keywords

CYTOCHROME; CYTOCHROME P450 1A1; CYTOCHROME P450 2A3; GLUTATHIONE TRANSFERASE M1; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER TISSUE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIAN; INJURY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MAXILLOFACIAL SURGERY; METABOLISM; MOUTH CANCER; PHARYNX CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TOBACCO;

ADENINE; ALCOHOL DRINKING; ARYL HYDROCARBON HYDROXYLASES; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; CYTOCHROME P-450 CYP1A1; CYTOSINE; DNA METHYLATION; FEMALE; GENE FREQUENCY; GLUTATHIONE TRANSFERASE; GUANINE; HEAD AND NECK NEOPLASMS; HUMANS; INDIA; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SMOKING; THYMINE;

EID: 77956827740     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01676.x     Document Type: Article

References (38)

1. Anantharaman D, Chaubal PM, Kannan S, et al. (2007). Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28 : 1455 1462.
2. Anttila S, Hakkola J, Tuominen P, et al. (2003). Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking. Cancer Res 63 : 8623 8628.
3. Belinsky SA, Nikula KJ, Baylin SB, et al. (1996). Increased cytosine DNA-methyltransferase activity is target-cell-specific and a nearly event in lung cancer. Proc Natl Acad Sci USA 93 : 4045 4050.
4. Cauffiez C, Lo-Guidice JM, Quaranta S, et al. (2004). Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochem Biophys Res Commun 317 : 662 669.
5. Cauffiez C, Pottier N, Tournel G, et al. (2005). CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations. Xenobiotica 35 : 661 669.
6. Cha IH, Park JY, Chung WY, et al. (2007). Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J 48 : 233 239.
7. Chen K, Sawhney R, Khan M, et al. (2007). Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 133 : 1131 1138.
8. Choi SY, Kahyo H (1991). Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol 20 : 878 885.
9. Czekaj P, Wiaderkiewicz A, Florek E, et al. (2005). Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta. Arch Toxicol 79 : 13 24.
10. Gattas GJ, de Carvalho MB, Siraque MS, et al. (2006). Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 28 : 819 826.
11. Geisler SA, Olshan AF (2001). GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 154 : 95 105.
12. Hasegawa M, Nelson HH, Peters E, et al. (2002). Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 21 : 4231 4236.
13. Hecht SS (2001). Tobacco smoke carcinogens and lung cancer. J Nat Cancer Inst 91 : 1194 1210.
14. Herman JG, Graff JR, Myohanen S, et al. (1996). Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 : 9821 9826.
15. Jiang JH, Jia WH, Chen HK, et al. (2004). Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population. J Transl Med 2 : 24 32.
16. Jourenkova-Mironova N, Voho A, Bouchardy C, et al. (1999). Glutathione S-transferase GSTM1, GSTM3, GSTP1, and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 81 : 44 48.
17. Kang MY, Lee BB, Ji YI, et al. (2008). Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Cancer 112 : 1699 1707.
18. Kawajiri K (1999). CYP1A1. IARC Sci Publ 148 : 159 172.
19. Kawakami K, Ruszkiewicz A, Bennett G, et al. (2006). DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer 94 : 593 598. (Pubitemid 43289765)
20. Le Q-T, Giaccia AJ (2003). Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer. Clin Cancer Res 9 : 4287 4295.
21. Li Y, Millikan RC, Bell DA, et al. (2004). Cigarette smoking, cytochrome p4501A1 polymorphisms and breast cancer among African-American and white women. Breast Cancer Res 6 : 460 473.
22. Lodygin D, Epanchitsev A, Menssen A, et al. (2005). Functional epigenomics identifies genes frequently silenced in prostrate cancer. Cancer Res 65 : 4218 4227.
23. Nakajima M, Iwanari M, Yokoi T (2003). Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inucible expressions of human CYP1 family in MCF-7 and HeLa cells. Toxicol Lett 144 : 247 256.
24. Nan HM, Song YJ, Yun HY, et al. (2005). Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol 11 : 3834 3841.
25. Nephew KP, Huang TH (2003). Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190 : 125 133.
26. Okino ST, Pookot D, Li LC, et al. (2006). Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res 66 : 7420 7428.
27. Olshan AF, Weissler MC, Watson MA, et al. (2000). GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 9 : 185 191.
28. Park JY, Muscat JE, Ren Q, et al. (1997). CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 6 : 791 797.
29. Parkin DM, Bray F, Ferlay J, et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55 : 74 108.
30. Puri SK, Si L, Fan CY, et al. (2005). Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 26 : 12 17.
31. Rodenhiser D, Mann M (2006). Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174 : 341 348.
32. Sanchez-Cespedes M, Esteller M, Wu L, et al. (2000). Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60 : 892 895.
33. Siraj AK, Ibrahim M, Al-Rasheed M, et al. (2007). Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East. Ann Hematol 86 : 887 895.
34. Smith G, Stanley LA, Sim E, et al. (1995). Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25 : 27 65.
35. Takahashi Y, Suzuki C, Kamataki T (1998). Silencing of CYP1A1 expression in rabbits by DNA methylation. Biochem Biophys Res Commun 247 : 383 386.
36. von Zeidler SV, Miracca EC, Nagai MA, et al. (2004). Hypermethylation of the p16 gene in normal oral mucosa of smokers. Int J Mol Med 14 : 807 811.
37. Vertino PM, Yen RW, Gao J, et al. (1996). De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)- methyltransferase. Mol Cell Biol 16 : 4555 4565.
38. Wong TS, Man MW, Lam AK, et al. (2003). The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer 39 : 1881 1887.